穿皮肺植入原生右心室外流通道使用MyvalTM而没有预先支架
João Luiz Langer Manica1,2, Raul Ivo Rossi Filho1,2, Carlos Augusto Cardoso Pedra3
1Instituto de Cardiologia Porto Alegre Brazil.
Health science reports
|April 11, 2025
概括
新的MyValTM门为大本源右心室外流管 (RVOT) 功能障碍提供安全有效的皮肤间治疗. 这项研究表明,在以前不适合其他手术的患者中,在不进行前置支架的情况下成功植入.
科学领域:
- 心血管外科心血管外科
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 穿皮肺植入 (PPVI) 是管道功能障碍的替代方案.
- 现有的PPVI选择对大型本土右心室外流通道 (RVOTs) 有局限性.
- 30.5和32毫米的MyValTM气球可扩展门为这些患者提供了新的可能性.
研究的目的:
- 为了评估30.5和32毫米MyValTM门的穿皮植入的直接结果.
- 在没有预先支架的情况下,评估本地和大型RVOT的疗效.
主要方法:
- 17名患有功能障碍本源RVOT的患者接受了PPVI.
- 植入30.5毫米 (n=5) 和32毫米 (n=12) 的MyValTM门是直接进行的,没有预先进行支架.
- 患者平均年龄为26.2岁;平均RVOT直径为27.6毫米.
主要成果:
- 所有患者在植入后立即实现了令人满意的门功能.
- 平均住院时间为3.2天.
- 在任何一个程序中都不需要预先进行支架.
结论:
- 30.5和32毫米的MyValTM门是通过皮肤治疗大型本地RVOT的安全和有效选择.
- 这些门为手术修复和现有的穿皮方法提供了可行的替代方案.
- 这种技术扩大了复杂的RVOT病症患者的治疗选择.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


